|
OMIM |
Link |
Information gain |
01 |
|
ALD
|
[NCBI]
|
0.0112031
|
|
|
red cell phospholipid defect with hemolysis
|
[NCBI]
|
0.00313132
|
|
|
medium chain 3-ketoacyl-coa thiolase deficiency
|
[NCBI]
|
0.00226391
|
|
|
schopf-schulz-passarge syndrome
|
[NCBI]
|
0.00226391
|
|
|
ATHS
|
[NCBI]
|
0.0022123
|
|
|
fatty metamorphosis of viscera
|
[NCBI]
|
0.00141752
|
|
|
carnitine deficiency, myopathic
|
[NCBI]
|
0.00104484
|
|
|
ZS
|
[NCBI]
|
0.000987445
|
|
|
DHS
|
[NCBI]
|
0.000943848
|
|
|
LPL
|
[NCBI]
|
0.000928476
|
|
|
SLE
|
[NCBI]
|
0.000918638
|
|
|
refsum disease
|
[NCBI]
|
0.000809025
|
|
|
PPARA
|
[NCBI]
|
0.000797687
|
|
|
GPS
|
[NCBI]
|
0.000730847
|
|
|
RA
|
[NCBI]
|
0.000619515
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
0.000579055
|
|
|
SCD
|
[NCBI]
|
0.000570593
|
|
|
CD36
|
[NCBI]
|
0.000518561
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
0.000489623
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
0.000438114
|
|
|
ACADM
|
[NCBI]
|
0.000432472
|
|
|
MADD
|
[NCBI]
|
0.000424044
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
0.000393731
|
|
|
ABCD1
|
[NCBI]
|
0.000375703
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
0.000357916
|
|
|
SLC25A20
|
[NCBI]
|
0.00029731
|
|
|
UCP3
|
[NCBI]
|
0.000293781
|
|
|
CDSP
|
[NCBI]
|
0.000288625
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
0.000239919
|
|
|
peroxisomal acyl-coa oxidase deficiency
|
[NCBI]
|
0.000232993
|
|
|
PBD
|
[NCBI]
|
0.000215612
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
0.000215612
|
|
|
carnitine palmitoyltransferase i deficiency
|
[NCBI]
|
0.00020711
|
|
|
CMH
|
[NCBI]
|
0.000196355
|
|
|
SLC27A1
|
[NCBI]
|
0.000193014
|
|
|
FABP3
|
[NCBI]
|
0.000170009
|
|
|
refsum disease, infantile form
|
[NCBI]
|
0.000149623
|
|
|
APOB
|
[NCBI]
|
0.000142023
|
|
|
acyl-coa dehydrogenase, long-chain, deficiency of
|
[NCBI]
|
0.000140455
|
|
|
IVA
|
[NCBI]
|
0.000129846
|
|
|
DBI
|
[NCBI]
|
0.000124974
|
|
|
FASN
|
[NCBI]
|
0.000123993
|
|
|
HADHA
|
[NCBI]
|
0.000119225
|
|
|
acyl-coa dehydrogenase family, member 9, deficiency of
|
[NCBI]
|
0.000117587
|
|
|
bile acid, synthetic defect of
|
[NCBI]
|
0.000117587
|
|
|
spastic paraparesis and deafness
|
[NCBI]
|
0.000117587
|
|
|
wolman disease with hypolipoproteinemia and acanthocytosis
|
[NCBI]
|
0.000117587
|
|
|
FAAH
|
[NCBI]
|
0.000108883
|
|
|
LCAT
|
[NCBI]
|
0.000105339
|
|
|
UCP1
|
[NCBI]
|
0.000100404
|
|
|
HSD17B4
|
[NCBI]
|
9.37371e-05
|
|
|
SLS
|
[NCBI]
|
9.3273e-05
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
9.17636e-05
|
|
|
ACACA
|
[NCBI]
|
9.10057e-05
|
|
|
VEGF
|
[NCBI]
|
8.71071e-05
|
|
|
acrogeria, gottron type
|
[NCBI]
|
8.61267e-05
|
|
|
carnitine acetyltransferase deficiency
|
[NCBI]
|
8.61267e-05
|
|
|
glutaryl-coa oxidase deficiency
|
[NCBI]
|
8.61267e-05
|
|
|
corpus callosum, partial agenesis of, x-linked
|
[NCBI]
|
8.61267e-05
|
|
|
long chain fatty acids, defect in transport of
|
[NCBI]
|
8.61267e-05
|
|
|
ACOX1
|
[NCBI]
|
8.52196e-05
|
|
|
FABP2
|
[NCBI]
|
8.42028e-05
|
|
|
SLC27A6
|
[NCBI]
|
8.10717e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
7.94262e-05
|
|
|
AHC
|
[NCBI]
|
7.76954e-05
|
|
|
FA2H
|
[NCBI]
|
7.51134e-05
|
|
|
bietti crystalline corneoretinal dystrophy
|
[NCBI]
|
7.43339e-05
|
|
|
gastritis, familial giant hypertrophic
|
[NCBI]
|
7.43339e-05
|
|
|
ceroid storage disease
|
[NCBI]
|
7.43339e-05
|
|
|
ACADS
|
[NCBI]
|
7.11839e-05
|
|
|
PPARD
|
[NCBI]
|
6.96684e-05
|
|
|
SCP2
|
[NCBI]
|
6.88912e-05
|
|
|
FABP4
|
[NCBI]
|
6.75671e-05
|
|
|
HHF4
|
[NCBI]
|
6.67216e-05
|
|
|
3-@hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
6.67216e-05
|
|
|
SLC27A4
|
[NCBI]
|
6.48409e-05
|
|
|
ELOVL2
|
[NCBI]
|
6.20605e-05
|
|
|
CROT
|
[NCBI]
|
6.20605e-05
|
|
|
OKS
|
[NCBI]
|
6.10947e-05
|
|
|
bile acid synthesis defect, congenital, 4
|
[NCBI]
|
6.10947e-05
|
|
|
PRKAA2
|
[NCBI]
|
6.05031e-05
|
|
|
ALDH3A2
|
[NCBI]
|
5.74204e-05
|
|
|
CF
|
[NCBI]
|
5.72111e-05
|
|
|
FPLD3
|
[NCBI]
|
5.66373e-05
|
|
|
NPHP3
|
[NCBI]
|
5.66373e-05
|
|
|
encephalopathy, ethylmalonic
|
[NCBI]
|
5.66373e-05
|
|
|
EGFR
|
[NCBI]
|
5.59528e-05
|
|
|
ADRP
|
[NCBI]
|
5.56561e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
5.53421e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
5.35128e-05
|
|
|
RCDP2
|
[NCBI]
|
5.29525e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
5.29525e-05
|
|
|
CEACAM5
|
[NCBI]
|
5.25952e-05
|
|
|
FABP5
|
[NCBI]
|
5.18513e-05
|
|
|
ELOVL3
|
[NCBI]
|
5.18513e-05
|
|
|
AD
|
[NCBI]
|
5.16012e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
4.98169e-05
|
|
|
KLK3
|
[NCBI]
|
4.90552e-05
|
|
|
ACADVL
|
[NCBI]
|
4.72745e-05
|
|
|
ACAD9
|
[NCBI]
|
4.7246e-05
|
|
|
PARK1
|
[NCBI]
|
4.7092e-05
|
|
|
NIDDM
|
[NCBI]
|
4.63792e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
4.46858e-05
|
|
|
CPT2
|
[NCBI]
|
4.43372e-05
|
|
|
ABL
|
[NCBI]
|
4.43071e-05
|
|
|
SLC27A5
|
[NCBI]
|
4.40897e-05
|
|
|
EGF
|
[NCBI]
|
4.27504e-05
|
|
|
ACHE
|
[NCBI]
|
4.1846e-05
|
|
|
SLC27A2
|
[NCBI]
|
4.16747e-05
|
|
|
NGFB
|
[NCBI]
|
4.11379e-05
|
|
|
STGD3
|
[NCBI]
|
4.05908e-05
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
4.05908e-05
|
|
|
sudden infant death syndrome
|
[NCBI]
|
4.05908e-05
|
|
|
GFAP
|
[NCBI]
|
4.00649e-05
|
|
|
ABCD2
|
[NCBI]
|
3.97161e-05
|
|
|
CJD
|
[NCBI]
|
3.89392e-05
|
|
|
MDD
|
[NCBI]
|
3.88387e-05
|
|
|
CDS
|
[NCBI]
|
3.7197e-05
|
|
|
CRAT
|
[NCBI]
|
3.66457e-05
|
|
|
PRL
|
[NCBI]
|
3.62461e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
3.5699e-05
|
|
|
ACACB
|
[NCBI]
|
3.53947e-05
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
3.43097e-05
|
|
|
PEX12
|
[NCBI]
|
3.42784e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
3.40081e-05
|
|
|
GIP
|
[NCBI]
|
3.36716e-05
|
|
|
AMACR
|
[NCBI]
|
3.34146e-05
|
|
|
DGAT1
|
[NCBI]
|
3.32708e-05
|
|
|
CRC
|
[NCBI]
|
3.32414e-05
|
|
|
HADH
|
[NCBI]
|
3.23528e-05
|
|
|
PCNA
|
[NCBI]
|
3.22574e-05
|
|
|
PC
|
[NCBI]
|
3.16335e-05
|
|
|
UCP2
|
[NCBI]
|
3.13149e-05
|
|
|
ELOVL1
|
[NCBI]
|
3.1027e-05
|
|
|
HSD17B12
|
[NCBI]
|
3.1027e-05
|
|
|
FAAH2
|
[NCBI]
|
3.1027e-05
|
|
|
CYP2U1
|
[NCBI]
|
3.1027e-05
|
|
|
CRH
|
[NCBI]
|
3.08526e-05
|
|
|
CPT1A
|
[NCBI]
|
3.07312e-05
|
|
|
GNPAT
|
[NCBI]
|
3.07312e-05
|
|
|
RCDP1
|
[NCBI]
|
3.06699e-05
|
|
|
blood group, p system
|
[NCBI]
|
3.06699e-05
|
|
|
CVS
|
[NCBI]
|
2.9601e-05
|
|
|
USH2A
|
[NCBI]
|
2.9601e-05
|
|
|
AVP
|
[NCBI]
|
2.94566e-05
|
|
|
EPO
|
[NCBI]
|
2.9403e-05
|
|
|
PNPLA2
|
[NCBI]
|
2.93316e-05
|
|
|
AAA
|
[NCBI]
|
2.85922e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
2.85922e-05
|
|
|
VIP
|
[NCBI]
|
2.82051e-05
|
|
|
ALOX5
|
[NCBI]
|
2.81013e-05
|
|
|
RP
|
[NCBI]
|
2.77096e-05
|
|
|
UOX
|
[NCBI]
|
2.76377e-05
|
|
|
G6PD
|
[NCBI]
|
2.75955e-05
|
|
|
FED
|
[NCBI]
|
2.50539e-05
|
|
|
BDNF
|
[NCBI]
|
2.37025e-05
|
|
|
CPT1C
|
[NCBI]
|
2.36198e-05
|
|
|
dual adaptor of phosphotyrosine and 3-phosphoinositides 1
|
[NCBI]
|
2.36198e-05
|
|
|
ACAA2
|
[NCBI]
|
2.36198e-05
|
|
|
EHHADH
|
[NCBI]
|
2.36198e-05
|
|
|
GPSN2
|
[NCBI]
|
2.36198e-05
|
|
|
SLC27A3
|
[NCBI]
|
2.36198e-05
|
|
|
PEX11G
|
[NCBI]
|
2.36198e-05
|
|
|
TYSND1
|
[NCBI]
|
2.36198e-05
|
|
|
cytochrome p450, family 4, subfamily v, polypeptide 2
|
[NCBI]
|
2.36198e-05
|
|
|
ANKRD23
|
[NCBI]
|
2.36198e-05
|
|
|
PITPNB
|
[NCBI]
|
2.36198e-05
|
|
|
SLC22A5
|
[NCBI]
|
2.35291e-05
|
|
|
CHAC
|
[NCBI]
|
2.35276e-05
|
|
|
AEZ
|
[NCBI]
|
2.35276e-05
|
|
|
CD
|
[NCBI]
|
2.34654e-05
|
|
|
CCK
|
[NCBI]
|
2.08507e-05
|
|
|
PEX11A
|
[NCBI]
|
2.08341e-05
|
|
|
LY96
|
[NCBI]
|
2.08341e-05
|
|
|
PEX11B
|
[NCBI]
|
2.08341e-05
|
|
|
PKN2
|
[NCBI]
|
2.08341e-05
|
|
|
PLSCR3
|
[NCBI]
|
2.08341e-05
|
|
|
FACL3
|
[NCBI]
|
2.08341e-05
|
|
|
CHAT
|
[NCBI]
|
2.06436e-05
|
|
|
FCHL
|
[NCBI]
|
2.0244e-05
|
|
|
PPARG
|
[NCBI]
|
2.00025e-05
|
|
|
NPY
|
[NCBI]
|
1.99695e-05
|
|
|
GRIA2
|
[NCBI]
|
1.99037e-05
|
|
|
PYY
|
[NCBI]
|
1.96543e-05
|
|
|
ADIPOQ
|
[NCBI]
|
1.94137e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
1.91779e-05
|
|
|
FACL5
|
[NCBI]
|
1.90309e-05
|
|
|
EIF2AK4
|
[NCBI]
|
1.90309e-05
|
|
|
LASS1
|
[NCBI]
|
1.90309e-05
|
|
|
TRIB3
|
[NCBI]
|
1.90309e-05
|
|
|
UBR1
|
[NCBI]
|
1.90309e-05
|
|
|
ACADL
|
[NCBI]
|
1.90309e-05
|
|
|
wolman disease
|
[NCBI]
|
1.85044e-05
|
|
|
SLC5A8
|
[NCBI]
|
1.76942e-05
|
|
|
SQLE
|
[NCBI]
|
1.76942e-05
|
|
|
ETFA
|
[NCBI]
|
1.76942e-05
|
|
|
FADS1
|
[NCBI]
|
1.76942e-05
|
|
|
ABCD3
|
[NCBI]
|
1.76942e-05
|
|
|
SH3GLB1
|
[NCBI]
|
1.76942e-05
|
|
|
HGF
|
[NCBI]
|
1.72991e-05
|
|
|
BTHS
|
[NCBI]
|
1.70572e-05
|
|
|
glycogen storage disease vii
|
[NCBI]
|
1.70572e-05
|
|
|
WBSCR14
|
[NCBI]
|
1.66322e-05
|
|
|
PSCD3
|
[NCBI]
|
1.66322e-05
|
|
|
PRKAA1
|
[NCBI]
|
1.66322e-05
|
|
|
RFWD2
|
[NCBI]
|
1.66322e-05
|
|
|
CAMK4
|
[NCBI]
|
1.57519e-05
|
|
|
ADIPOR2
|
[NCBI]
|
1.57519e-05
|
|
|
ACAT2
|
[NCBI]
|
1.57519e-05
|
|
|
PCK2
|
[NCBI]
|
1.57519e-05
|
|
|
TLR4
|
[NCBI]
|
1.55689e-05
|
|
|
SLC2A4
|
[NCBI]
|
1.54443e-05
|
|
|
DBN1
|
[NCBI]
|
1.50006e-05
|
|
|
NFE2L1
|
[NCBI]
|
1.50006e-05
|
|
|
FMF
|
[NCBI]
|
1.44905e-05
|
|
|
CHS
|
[NCBI]
|
1.44097e-05
|
|
|
FACL2
|
[NCBI]
|
1.43458e-05
|
|
|
PITPN
|
[NCBI]
|
1.43458e-05
|
|
|
AIPL1
|
[NCBI]
|
1.43458e-05
|
|
|
ACVR1C
|
[NCBI]
|
1.43458e-05
|
|
|
PEX6
|
[NCBI]
|
1.43458e-05
|
|
|
ELOVL4
|
[NCBI]
|
1.43458e-05
|
|
|
LCN2
|
[NCBI]
|
1.38688e-05
|
|
|
LTB4R
|
[NCBI]
|
1.37659e-05
|
|
|
srebp cleavage-activating protein
|
[NCBI]
|
1.37659e-05
|
|
|
SREBF2
|
[NCBI]
|
1.37659e-05
|
|
|
NR0B2
|
[NCBI]
|
1.36158e-05
|
|
|
SNCA
|
[NCBI]
|
1.325e-05
|
|
|
PEX1
|
[NCBI]
|
1.32458e-05
|
|
|
INSIG2
|
[NCBI]
|
1.32458e-05
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
1.29813e-05
|
|
|
GSS
|
[NCBI]
|
1.27747e-05
|
|
|
PON2
|
[NCBI]
|
1.27747e-05
|
|
|
AR
|
[NCBI]
|
1.23893e-05
|
|
|
PXMP3
|
[NCBI]
|
1.23442e-05
|
|
|
NR1H3
|
[NCBI]
|
1.19482e-05
|
|
|
PLTP
|
[NCBI]
|
1.14558e-05
|
|
|
MBTPS1
|
[NCBI]
|
1.12408e-05
|
|
|
PLA2G2A
|
[NCBI]
|
1.09222e-05
|
|
|
CERK
|
[NCBI]
|
1.09222e-05
|
|
|
LRAT
|
[NCBI]
|
1.09222e-05
|
|
|
LIPC
|
[NCBI]
|
1.08884e-05
|
|
|
NPPA
|
[NCBI]
|
1.06724e-05
|
|
|
ADIPOR1
|
[NCBI]
|
1.06234e-05
|
|
|
PFKM
|
[NCBI]
|
1.0342e-05
|
|
|
SREBF1
|
[NCBI]
|
1.0342e-05
|
|
|
ASS
|
[NCBI]
|
1.01295e-05
|
|
|
TXNIP
|
[NCBI]
|
1.00764e-05
|
|
|
VCAM1
|
[NCBI]
|
1.00764e-05
|
|
|
LBP
|
[NCBI]
|
1.00498e-05
|
|
|
DNM1L
|
[NCBI]
|
9.82487e-06
|
|
|
RXRA
|
[NCBI]
|
9.5861e-06
|
|
|
GAL3ST1
|
[NCBI]
|
9.35894e-06
|
|
|
gaucher disease, type i
|
[NCBI]
|
9.17338e-06
|
|
|
asthma, susceptibility to
|
[NCBI]
|
8.23909e-06
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
8.01966e-06
|
|
|
F3
|
[NCBI]
|
7.88459e-06
|
|
|
CAV1
|
[NCBI]
|
7.8603e-06
|
|
|
CES1
|
[NCBI]
|
7.8603e-06
|
|
|
IRS2
|
[NCBI]
|
7.55281e-06
|
|
|
AQP3
|
[NCBI]
|
7.40684e-06
|
|
|
NR1H4
|
[NCBI]
|
7.26565e-06
|
|
|
GPX1
|
[NCBI]
|
7.26565e-06
|
|
|
ADH5
|
[NCBI]
|
7.12896e-06
|
|
|
PON1
|
[NCBI]
|
7.06358e-06
|
|
|
CREM
|
[NCBI]
|
6.99651e-06
|
|
|
JAK1
|
[NCBI]
|
6.86809e-06
|
|
|
CST3
|
[NCBI]
|
6.74348e-06
|
|
|
GK
|
[NCBI]
|
6.50493e-06
|
|
|
MB
|
[NCBI]
|
6.46314e-06
|
|
|
PEMT
|
[NCBI]
|
6.06584e-06
|
|
|
MBP
|
[NCBI]
|
6.02172e-06
|
|
|
CAT
|
[NCBI]
|
5.8131e-06
|
|
|
GDNF
|
[NCBI]
|
5.45565e-06
|
|
|
MYH7
|
[NCBI]
|
5.39778e-06
|
|
|
GALP
|
[NCBI]
|
5.06252e-06
|
|
|
phenylketonuria
|
[NCBI]
|
4.81311e-06
|
|
|
LS
|
[NCBI]
|
4.70811e-06
|
|
|
ATF3
|
[NCBI]
|
4.61076e-06
|
|
|
IRS1
|
[NCBI]
|
4.40469e-06
|
|
|
TF
|
[NCBI]
|
4.31683e-06
|
|
|
DNTT
|
[NCBI]
|
4.21022e-06
|
|
|
GAPDH
|
[NCBI]
|
4.00017e-06
|
|
|
TFF3
|
[NCBI]
|
3.85216e-06
|
|
|
APOD
|
[NCBI]
|
3.74105e-06
|
|
|
ADA
|
[NCBI]
|
3.39336e-06
|
|
|
TTR
|
[NCBI]
|
3.17611e-06
|
|
|
MTR
|
[NCBI]
|
3.1471e-06
|
|
|
GPT
|
[NCBI]
|
3.05873e-06
|
|
|
STAT6
|
[NCBI]
|
3.05873e-06
|
|
|
TRPV1
|
[NCBI]
|
2.97304e-06
|
|
|
LCT
|
[NCBI]
|
2.80923e-06
|
|
|
FGF7
|
[NCBI]
|
2.70598e-06
|
|
|
fabry disease
|
[NCBI]
|
2.66962e-06
|
|
|
PTGS2
|
[NCBI]
|
2.37135e-06
|
|
|
CFTR
|
[NCBI]
|
2.15496e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.14556e-06
|
|
|
TFPI
|
[NCBI]
|
1.89932e-06
|
|
|
CFH
|
[NCBI]
|
1.8101e-06
|
|
|
LDLR
|
[NCBI]
|
1.80252e-06
|
|
|
ABCC8
|
[NCBI]
|
1.68417e-06
|
|
|
APOE
|
[NCBI]
|
1.60456e-06
|
|
|
ALB
|
[NCBI]
|
1.56672e-06
|
|
|
INSR
|
[NCBI]
|
1.52077e-06
|
|
|
PMCH
|
[NCBI]
|
1.4868e-06
|
|
|
SOD2
|
[NCBI]
|
1.41405e-06
|
|
|
INS
|
[NCBI]
|
1.39927e-06
|
|
|
RB1
|
[NCBI]
|
1.37106e-06
|
|
|
TNF
|
[NCBI]
|
1.2873e-06
|
|
|
CYP1A1
|
[NCBI]
|
1.1804e-06
|
|
|
GC
|
[NCBI]
|
1.14267e-06
|
|
|
PF4
|
[NCBI]
|
1.07877e-06
|
|
|
LEP
|
[NCBI]
|
1.07371e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
9.87266e-07
|
|
|
AFP
|
[NCBI]
|
7.5744e-07
|
|
|
PNPLA6
|
[NCBI]
|
7.49173e-07
|
|
|
ACE
|
[NCBI]
|
5.62832e-07
|
|
|
PD
|
[NCBI]
|
5.61304e-07
|
|
|
GAL
|
[NCBI]
|
4.5815e-07
|
|
|
XDH
|
[NCBI]
|
4.4322e-07
|
|
|
MPO
|
[NCBI]
|
4.23262e-07
|
|
|
HD
|
[NCBI]
|
3.87685e-07
|
|
|
CNTF
|
[NCBI]
|
3.25012e-07
|
|
|
DCK
|
[NCBI]
|
3.24236e-07
|
|
|
PEDF
|
[NCBI]
|
3.16983e-07
|
|
|
ABP1
|
[NCBI]
|
2.50003e-07
|
|
|
FRAP1
|
[NCBI]
|
1.0654e-07
|
|
|
TLR2
|
[NCBI]
|
1.03184e-07
|
|
|
ADCYAP1
|
[NCBI]
|
9.82636e-08
|
|
|
SOD1
|
[NCBI]
|
4.38799e-08
|
|
|
TSD
|
[NCBI]
|
2.40247e-08
|
|
|
MAP2
|
[NCBI]
|
1.40514e-08
|
|
|
SHH
|
[NCBI]
|
8.98944e-09
|
|
|
NR1I2
|
[NCBI]
|
6.73776e-09
|
|
|
IAPP
|
[NCBI]
|
8.43528e-10
|
|